BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
Keyword: Sodium-glucose cotransporter 2 inhibitors
1
Beyond glycemic control: Roles of sodium-glucose cotransporter 2 inhibitors and glucagon-like peptide-1 receptor agonists in diabetic kidney disease
6/13/2025 11:47:49 AM | Browse: 6 | Download: 0
2
Sodium-dependent glucose transporter 2 inhibitors improve heart function in patients with type 2 diabetes and heart failure
1/21/2025 6:56:34 AM | Browse: 31 | Download: 103
3
Dual benefits of sodium-glucose cotransporter 2 inhibitors in metabolic diseases: Diabetes control and gout management
1/15/2025 3:58:00 AM | Browse: 42 | Download: 124
4
Potential for sodium-glucose cotransporter-2 inhibitors in the management of metabolic syndrome: A systematic review and meta-analysis
11/24/2022 8:01:57 AM | Browse: 435 | Download: 920
5
Chances and risks of sodium-glucose cotransporter 2 inhibitors in solid organ transplantation: A review of literatures
7/13/2021 9:21:26 AM | Browse: 534 | Download: 971
6
Sodium-glucose co-transporter-2 inhibitor-associated euglycemic diabetic ketoacidosis that prompted the diagnosis of fulminant type-1 diabetes: A case report
4/22/2021 12:14:43 PM | Browse: 406 | Download: 1328
7
Sodium-glucose cotransporter 2 inhibitors’ mechanisms of action in heart failure
7/14/2020 6:33:18 AM | Browse: 856 | Download: 1647
8
Rise of sodium-glucose cotransporter 2 inhibitors in the management of nonalcoholic fatty liver disease
7/26/2019 11:08:19 AM | Browse: 882 | Download: 1347
9
Effects of glucose-lowering agents on cardiorespiratory fitness
12/14/2018 1:19:57 AM | Browse: 1057 | Download: 1278
Write to the Help Desk
© 2004-2025 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

California Corporate Number: 3537345